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Background: Lack of a United Kingdom (UK) fatal asthma registry has resulted in few
recent analyses regarding patient characteristics, co-morbidities, and admission type in
relation to mortality post an asthma admission. This study aims to report these factors in
addition to season of event for the years 2000–2005 to provide data regarding asthma
burden in the in-patient hospital setting.
Methods: Data were analysed from the CHKS database collated from UK National Health
Service data providing 70% of in-patient coverage in the UK. Patients with admissions under
ICD-10 codes J45 ‘‘Asthma’’ and J46 ‘‘acute severe asthma’’ were included. Codes for
associated co-morbidity at time of admission were identified, as well as month of
admission and death, age, gender and length of stay.
Results: The mortality rate over the 5-year period was 1063 patients from 250,043 asthma
admissions (0.43%). Critical care mortality was far higher and an annual rate indicated that
for every 100,000 admissions 2878 (95% CI 2091;3857) patients died. Respiratory infection,
cardiovascular disease and diabetes were common co-morbidities for all admissions.
December and January had the peak number of deaths post asthma admission which were
nearly all in adults, death being rarer in children. Women and those over 45 years had the
highest rate of death which may reflect asthma prevalence.
Conclusions: Co-morbid conditions experienced by older asthma patients may contribute
to mortality post an asthma admission and greater understanding of risk factors
contributing to fatality are required.
& 2007 Published by Elsevier Ltd.Published by Elsevier Ltd.
tis.com (F. Turk).
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Asthma is generally considered a chronic disease charac-
terised by comparatively low mortality risk when com-
pared to other chronic diseases such as cardiovascular
disease. Within the United Kingdom (UK) there is
currently no fatal asthma registry and long-term observa-
tional data assessing mortality risk and the severity of the
asthma event associated with subsequent death are rela-
tively scant elsewhere. The asthma mortality rate has
certainly fallen over the last 15 years in most developed
countries1–4 and this has been linked to increased use of
inhaled corticosteroids2 and improved management result-
ing in reduced exacerbations in many patients.5 However, to
our knowledge there are no current UK data available
evaluating patient characteristics, time in hospital and
subsequent survival or mortality during the asthma admis-
sion spell. These data are important when assessing the
economic and disease burden impact of asthma on any
health system.
Some population studies have shown that risk of
mortality remains greater in asthma patients despite the
observed overall decline in mortality rate. De Marco et al.6
reported that in a cohort of 6031 Italian adults aged
20–44 years followed from 1991 to 1999, the excess
mortality risk in asthmatic subjects was 2.05 (95% CI
1.06–3.58), mainly from causes other than asthma. Similar
findings were reported in studies of subjects with varying
ages, from Finland, France and Denmark.7–9 A US study of
hospitalised asthma patients reported that risk of death
was unsurprisingly higher than in the primary care popula-
tion and greater in those with severe co-morbidities
such as hypertension, diabetes and heart failure.10 Ringbaek
et al.9 additionally reported that ischaemic heart disease
and cor pulmonale were independent risk factors for
asthma death, diseases both associated with older age. In
a study of age specific trends in asthma mortality, decline in
mortality rate was shown in all age categories between 1983
and 1995 except in patients aged over 75 who had a stable
mortality rate.11 Understanding co-morbidity and age
related morbidity and mortality risk is important so that
high risk patients may be more easily identified and
managed appropriately.
Season has also been implicated as a risk factor in asthma
death. Hansell et al.12 reported that asthma deaths in the
UK between 1991 and 1995 occurred in December and
January but admissions peaked in September, mainly driven
by paediatric admissions. McCoy et al.13 report a winter
peak in a study of over 130,000 deaths in the US between
1990 and 2001 supported by Turner et al.14 who found that
fatal cases of asthma had a history of worse asthma during
January and February. However, Weiss15 reports a summer
trend of asthma death in the US population aged 5–34 years
during 1982–1986 which is discordant with the association of
co-morbid viral infection found in fatal asthma cases and
associated with the peak in autumn morbidity.13,16
The objective of this study was to evaluate the rate of
mortality in UK patients hospitalised for asthma between
2000 and 2005, the season of occurrence and to describe the
characteristics of patients who suffer fatal events, including
co-morbidities. These data help to describe the burden of
asthma in the UK hospital setting.Methods
Data were obtained from the ‘‘CHKS’’ database as it was
able to provide greater breadth of information than Office of
National Statistics data. CHKS Ltd. is a company that
provides benchmarking and analytical services to the UK
National Health Service (NHS). Data are provided in
anonymised form by the NHS Acute Trusts that subscribe
to the CHKS service and the database now provides up to
70% of in-patient coverage in the UK for the years 1992–2005
inclusive and contains over 100 million inpatient episodes
for England, Scotland, Wales and Northern Ireland. It should
be noted that data are not provided from the Accident
and Emergency (A&E) departments (equivalent to the
emergency room) where patients are discharged or die
on day of admission. Data are provided from hospitals
which have A&E departments that have admission beds,
and from short stay emergency wards. Data are taken
from 120 of 200 Acute Hospital Trusts that run hospitals
in the UK. Trusts are formed from groups of hospitals.
Critical care data are only provided by English Acute
Trusts to CHKS. Covariates contained within the database
include: Demographic information (age, sex).
 Reason for admission (ICD-10 diagnosis codes).
 Procedures undertaken (OPCS-4.2 coding).
 Date of admission.
 Length of stay.
 Outcomes (discharge, death).
All patients with ICD-10 codes J45 ‘‘Asthma’’ and all sub-codes J45.0 ‘‘predominantly allergic asthma, J45.1 ‘‘non-
allergic asthma’’, J45.8 ‘‘mixed asthma, J45.9 ‘‘asthma
unspecified’’ were included, plus J46 ‘‘acute severe asth-
ma’’ (status asthmaticus). These codes are applied in the
hospital by trained coders post discharge of the patient, and
are based on information from patients’ medical records. As
the coder is reliant on the information in the medical
record, interpretation of codes for admission should be
treated with caution. For that reason all J45 codes are
amalgamated. Patients were included for the years April 1,
2000–March 31, 2005. Patients were included regardless of
age or co-morbidity and no exclusion criteria were applied
to reflect a real world scenario. Mortality that occurred
during the admission spell (the period from a live admission
to either discharge or death) was reported per asthma
admission code and stratified where appropriate by gender
and age band: 0–11, 12–16, 17–44, X45. These age bands
were selected based on common prescribing banding for
asthma medications and to also categorise patients by age
groups that have differing mortality and morbidity risks in
the general population, as it important to assess if age
differences occur in a clinical population. For some analyses
such as length of stay, all ages were combined due to the
very low mortality numbers in paediatric patients. Regions
within the UK were studied but are not reported here, as
attempts to categorise by post-code or region biased
outputs as referral is not uniform from each area and
standardisation is not possible for underlying population
characteristics. Additionally, provision of specialist respira-
tory units also varied by area, which resulted in higher
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potentially higher rates of death. Thus regional death rates
were not able to be robustly compared.
ICD-10 codes for co-morbidities were collected and
length of hospital stay was calculated per admission. Month
of hospital admission was also collected. Deaths that
occurred post the asthma admission are for all causes
and not necessarily asthma, as the actual death certificate
is not recorded as part of the admission or discharge
record. The co-morbidities of the patient could have
contributed or caused death despite the admission being
for asthma.Table 1 Mortality per admission code, stratified by age band a
Diagnosis Age band
(years)
Asthma
admissions,
Asthma (J45) 011 82624
1216 11917
1744 62102
X45 67060
Total 223703
Acute severe asthma (J46) 011 8222
1216 1568
1744 9407
X45 7143
Total 26340
Female (all ages, all codes) 135011
Male (all ages, all codes) 115009
Table 2 Critical care unit (CCU) admissions and mortality data
Diagnosis Critical care admissions for
asthma, n
Asthma (J45) 937
Acute severe asthma (J46) 557
Total 1494
Additional deaths occurred in patients that were admitted to the
Table 3 Length of stay during the admission spell for asthma
Main diagnosis code Number of patients
admitted per code
Mean number o
days
J45 837 13.88
J46 226 10.98
Total 1063 13.26
The mean bed days are highly skewed due to outliers in the data
total resource use information which are lost if only restricted to mWe were not able to assess medication as, unfortunately,
the pharmacy data of hospitalised patients in the UK are not
recorded as part of the admission or discharge record. We
are not therefore able to ascertain if cause of death was
related to care or treatment.
The analyses performed were descriptive statistics. Con-
fidence intervals for the death rates post asthma admission
were created assuming a binomial distribution using the ‘Exact’
method.17 This was converted into deaths per 100,000 asthma
admissions by the obvious multiplication of the proportions by
100,000. Analysis was conducted using STATAV9.2. Comparative
statistics were performed using t-tests where appropriate.nd gender.
n
Deaths post asthma
admission, n
Deaths post 100,000
asthma admissions n
(95% CI)
3 4 (1;11)
4 34 (9;86)
32 52 (35;73)
798 1190 (1109;1275)
837 374 (349;400)
8 97 (42;191)
5 319 (104;742)
36 383 (267; 529)
177 2478 (2129;2865)
226 858 (750;977)
756 560 (520;601)
307 267 (238; 299)
provided by English hospitals for 2004.
Deaths in the critical care
unit post asthma
admission, n
CCU deaths per 100 000
asthma critical care
admissions, n (95% CI)
23 1720 (1094;2570)
20 3591 (2207; 5491)
43 2878 (2091;3857)
CCU post discharge from the unit (n ¼ 6).
patients prior to death.
f bed Std.
dev.
Median number of
bed days
IQ range
27.84 6 14
18.00 4 11
26.08 5 13
with very long stay. However, mean values are shown to provide
edian values.
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Table 4 Secondary co-morbidities associated with patients who died post admission for asthma, comparing J46 patients with J45 patients.
Asthma
admission
code
Secondary co-morbidity code Number of
patients with
secondary
code
% of patients
with secondary
code
Asthma
admission
code
Secondary co-morbidity code Number of
patients with
secondary
code
% of
patients
with
secondary
code
J46 I469—Cardiac arrest unspecified 32 14 J45 I469—Cardiac arrest unspecified 72 9
J46 G931—Anoxic brain damage not
elsewhere classified
28 12 J45 G931—Anoxic brain damage not
elsewhere classified
0 0
J46 I10X—Essential (primary)
hypertension
24 11 J45 I10X—Essential (primary)
hypertension
121 15
J46 I259—Chronic ischaemic heart
disease unspecified
20 9 J45 I259—Chronic ischaemic heart
disease unspecified
76 9
J46 I460—Cardiac arrest with
successful resuscitation
19 8 J45 I460—Cardiac arrest with
successful resuscitation
0 0
J46 E119—Non-insulin-depend
diabetes mellitus without
complication
18 8 J45 E119—Non-insulin-depend
diabetes mellitus without
complication
88 11
J46 J22X—Unspecified acute lower
respiratory infection
17 8 J45 J22X—Unspecified acute lower
respiratory infection
142 17
J46 A419—Septicaemia unspecified 15 7 J45 A419—Septicaemia unspecified 0 0
J46 J449—Chronic obstructive
pulmonary disease unspecified
14 6 J45 J449—Chronic obstructive
pulmonary disease unspecified
47 6
J46 I500—Congestive heart failure 13 6 J45 I500—Congestive heart failure 81 10
J46 J180— Bronchopneumonia
unspecified
13 6 J45 J180—Bronchopneumonia
unspecified
71 9
J46 J969—Respiratory failure
unspecified
13 6 J45 J969—Respiratory failure
unspecified
43 5
J46 N179—Acute renal failure
unspecified
13 6 J45 N179—Acute renal failure
unspecified
0 0
J46 I48X—Atrial fibrillation and
flutter
12 5 J45 I48X—Atrial fibrillation and
flutter
110 13
J46 J189—Pneumonia unspecified 0 0 J45 J189—Pneumonia unspecified 66 8
J46 I501—Left ventricular failure 0 0 J45 I501—Left ventricular failure 61 7
All conditions affecting less than 5% of patients are removed. Patients can contribute to more than one category.
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Figure 2 Sum of deaths post asthma admission by month adult
and paediatric combined.
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Mortality per ICD-10 admission code is shown in Table 1. The
highest proportion of patients who died following an acute
asthma admission is adults over 45 years of age. Females had
a predominantly higher rate of death. The total number of
deaths during the 5-year observation period was 1063
patients from 250,043 asthma admissions. When data are
considered as a rate, for every 100,000 patients admitted
for asthma over the 5-year period, acute severe asthma
patients (J46) had 858 deaths (95% CI 750;977) versus 374
(95% CI 349;400) for J45 coded patients. For those that died
following an acute severe asthma admission, the median age
at time of admission was 66 years (interquartile (IQ) range
30 years) versus 27 years (IQ range 38 years) for survivors.
The median age at admission for those dying following all
other types of asthma event was 77 years (IQ range 16 years)
versus 25 years (IQ range 44 years) for survivors.
Critical care admissions are shown in Table 2 for the year
2004 for English hospitals only. Critical care admissions
unsurprisingly have a much higher rate of death than other
types of admission. The death rate within the critical care
units in 2004 per 100,000 admissions were 2878 (95% CI
2091;3857).
Length of hospital stay is shown in Table 3 for patients who
died following asthma admission. Mean data are provided to
inform health economics as total resource use must be
documented and the mean is the only method suitable for
measuring the average for total values. Comparison of the
mean indicates that there was no statistically significant
difference between groups (p ¼ 0.06) regarding length of
stay for J46 and J45 codes and median stay was 4 and 6 days,
respectively. Of those who survived the median stay was 2
days for all types of asthma.
The co-morbidities of patients that died are shown in
Table 4. Respiratory tract infection was the most prevalent
co-morbidity for J45 admissions at 17%. Vascular disease and
diabetes were also common co-morbidities at time of
admission.0
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Figure 1 Sum of asthma admissions by month, adult and
paediatric data combined.Season of admissions are shown in Fig. 1 for all codes
combined, illustrating the autumn peak starting in September.
When we stratified this analysis by age, children particularly
contributed to the observed September peak, but it was not so
prevalent in adult admissions, which reached a peak by
December through to January. Deaths also peaked in
December and January as shown in Fig. 2. Stratified analysis
by age showed that of the 20 deaths in children during the
observation period, the majority were in the spring and
summer.Discussion
These analyses indicate that deaths of adults and children
post an asthma admission occur at a relatively low rate. For
those that enter critical care the rate is far higher with 1494
admissions and 43 deaths in one year in English hospital
critical care units. Deaths recorded in this database do not
include patients who die in the emergency department,
which may cause an under estimate of asthma death rate in
the UK hospital setting. Additionally, within the UK, of those
patients certified as dying from asthma in a survey of asthma
deaths between 1994 and 1998, 65% were reported to have
never been admitted to hospital in the year prior to death
and 57% never to have been admitted in the 5 years prior to
death.18 This implies that a proportion of patients in the UK
die outside the hospital setting, which should be considered
when assessing overall societal and economic asthma
burden.
As the death certificate is not available to validate cause
of death, we cannot attribute death to asthma with any
certainty. This is a problem typically found in all types of
database analyses. However, it seems reasonable to assume
that asthma was at least a contributory factor in the
majority of deaths due to death occurring in the same
admission spell, which lasted only a few days in the majority
of patients. Time between admission and death was 4 days
in acute severe asthma patients and 6 days in other types of
asthma admission. Additionally no secondary morbidity
codes were reported for the patient in over 80% of cases.
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additionally have contributed to death. The winter period
had a greater number of deaths each year than any other
time and these deaths were virtually all in adults.
These data support other reports regarding demographic
risk factors for asthma mortality and hospital admission
which include old age and female gender.3,12,14,19,20 The
higher female incidence of death post asthma admission
may be due to the gender bias in adult asthmatics where
females predominate.21,22 In severe asthma this ratio can be
as high as 4:1.23 Our data are supported by Sturdy et al. who
reported that 60% of UK asthma deaths were in older adult
females.18
The co-morbidities experienced by patients admitted
under a primary asthma code and who subsequently died are
informative, as research into the role of co-morbidity in
fatal asthma has been limited to date. Only a few
publications have included adjusted multi-variate modelling
to assess co-morbid risk factors for asthma admission and
death9,10 whilst much of the literature has tended to focus
on socio-demographics and clinical endpoints such as lung
function.13,24,25 Viral infection was a common co-morbidity
and of those that died in this current study only a small
minority were children indicating that infection is impacting
primarily in adult asthmatic patients. The viral infection
prevalence in fatal cases may be associated with the
observed peak in winter mortality, as viral infections peak
during the winter months and picornavirus and adenovirus in
particular have been associated with near-fatal asthma
cases.26 Additionally, whether infection interacts with other
co-morbidities such as heart disease or diabetes to
additionally increase risk of admission or death was not
able to be evaluated but requires further research.
This study has shown that females and those over 45 years
are at the highest risk of death post an asthma hospital
admission which may be related to co-morbidity, an area
under-reported in the respiratory literature.
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